Dr. Sinha has over ten years of experience in oncology, biopharmaceutical drug development and epidemiology. She earned her PhD from CDRI, Lucknow in 2009 in malaria epidemiology and population genetics. Dr. Sinha completed her postdoctoral fellowships at Institut de RecherchesCliniques de Montreal (IRCM), Canada and Colorado State University, USA where her research was focused on various aspects of gene regulation during cancer and cardiovascular diseases. Swapnil moved back to Guwahati in 2014 as a DST Women Scientist at NIPER-Guwahati from 2014 to 2017. During her time at NIPER, Dr. Sinha shifted her research interest to biopharmaceutical development. She worked on projects that were focused on generating Aptamers (DNA, peptide, Riboswitches and DNAzymes) for applications in cancer immunomodulation and Mtb pathogenesis. She nurtured the idea of using the Aptamers as diagnostic tools and conceptualized 'BioAptagen'. Swapnil founded the start-up "BioAptagen Laboratories" in September 2018. She secured the necessary early stage funding, BIG (Biotechnology Ignition Grant) sponsored by BIRAC, Govt. of India in 2018.
Dr. Swapnil Sinha, Director